<DOC>
	<DOCNO>NCT00542555</DOCNO>
	<brief_summary>To study efficacy safety naproxcinod vs. placebo naproxen treatment sign symptom Osteoarthritis .</brief_summary>
	<brief_title>Analgesic Efficacy Safety Study Naproxcinod Subjects With Osteoarthritis Knee</brief_title>
	<detailed_description>This 13-week double-blind study follow 52-week , open-label , roll-over active treatment study . These randomize , parallel group , multicenter study compare efficacy safety naproxcinod , placebo naproxen .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Naproxen-n-butyl nitrate</mesh_term>
	<criteria>Men woman ( 40 old ) diagnosis primary OA knee Must current chronic user NSAIDS acetaminophen Must discontinue analgesic therapy screen Uncontrolled hypertension diabetes Hepatic renal impairment Current expect use anticoagulant A history alcohol drug abuse Candidates imminent joint replacement Diagnosis gastric duodenal ulceration and/or history significant gastroduodenal bleeding , within last 6 month Current medical disease could confound interfere evaluation efficacy Participation within 30 day prior screen another investigational study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>